Latest Nephrology Stories
Commitment to Patient Care, Sustainability and Goodwill Continues to Grow DENVER, June 9, 2014 /PRNewswire/ -- DaVita Kidney
While Over 1,000 Dialysis Medication Lawsuits Await Litigation, Fresenius Medical Care North America Issues NaturaLyte Recall After Discovering its Dialysis Medication Could Have Higher Levels
Johns Hopkins Bloomberg School of Public Health A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials. If adopted, the new definition could shorten the length of some clinical trials and also potentially encourage more clinical trials in kidney disease. The findings will be published in the June...
The Firm is representing numerous clients in GranuFlo Lawsuits, all of which allege the use of GranuFlo or NaturaLyte dialysis concentrates caused serious, and sometimes deadly, heart injuries.
Company sponsors Walk to End Lupus Now(TM) events and employees show support for people with the disease during Lupus Awareness Month HAYWARD, Calif., June 3, 2014 /PRNewswire/ --
EHE International Donates Window Display to Promote Kidney Disease Awareness. NEW YORK, June 2, 2014 /PRNewswire-USNewswire/ -- One in three Americans is at risk for kidney disease.
DaVERT Shares Emergency Preparedness Tips for Hurricane Season DENVER, June 2, 2014 /PRNewswire/ --
Reduced kidney function may increase the risk of developing kidney and urothelial cancers.
OAKLAND, Calif., May 29, 2014 /PRNewswire/ -- A key measure of reduced kidney function and chronic kidney disease -- reduced glomerular filtration rate -- is an independent risk factor for renal and
WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- On May 30(th), nephrologists and kidney patients from across the country will convene in Washington to participate in the Renal Physicians Association's
Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...